Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Madaule, S.
Right arrow Articles by Arlet-Suau, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madaule, S.
Right arrow Articles by Arlet-Suau, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 1157-1158
© 2000 British Society for Rheumatology

Letters to the Editor

Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies

S. Madaule, L. Porte, B. Couret and E. Arlet-Suau

Service de Médecine Interne, Clinique Dieulafoy, CHU Toulouse-Purpan, 31059 Toulouse cedex, France

The first 10% of the full text of this article appears below.

SIR, In the December 1998 issue of Rheumatology, Yasuda et al. [1] described a haemophagocytic syndrome (HS) in a patient with dermatomyositis (DM). We report a second case.

An 83-yr-old man was admitted to hospital with muscle weakness, in particular of the pelvic girdle and associated myalgia of about 1 month's duration. He also presented cutaneous signs: heliotrope rash with oedema of the eyelids, the Gottron sign, nail-fold lesions and ragged . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?